Why the study?
Comprehensive data on the changing landscape of cardiovascular disease burden in cancer patients remained limited.
Population
1,322,502 adults aged ≥18 newly diagnosed with cancer in Korea
Comparison
Temporal trends from 2005 to 2022
Design
Nationwide population-based cohort study
Key result
Between 2005 and 2022, 1-year cardiovascular disease incidence in cancer patients initially decreased but later increased, driven by a 136% rise in heart failure incidence.
Authors
Loading...
May signal need for intensified HF monitoring in cancer survivors; hypothesis-generating for targeted cardio-oncology prevention strategies.
Cohort (n=1,322,502)
While cancer-specific mortality has improved, cardiovascular mortality in cancer patients is an increasing concern, driven largely by a rising burden of heart failure.
Cho et al. (2026) conducted a cohort in Cancer (n=1,322,502). Time period (2005-2022) was evaluated on Temporal trends in cardiovascular disease incidence and cause-specific mortality. Between 2005 and 2022, 1-year cardiovascular disease incidence in cancer patients initially decreased but later increased, driven by a 136% rise in heart failure incidence.